1 Product identity
Ingredient risk
No flagged ingredients

Transmax Tr

BrandBiotivia→Non-Nutrient/Non-Botanical Tablet or Pill 2 ingredients DSLD #33100
Net contents: 30 Time Release Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2014-05-23
2 Ingredients (2)
IngredientGroupSafety
98% Trans-Resveratrol Polygonum cuspidatum rhizome extractResveratrolConditionally Safe
500 mg of Trans-ResveratrolResveratrolConditionally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Resveratrol — Conditionally Safe
⚠ Estrogenic activity
⚠ CYP enzyme inhibition
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID33100
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2014-05-23
6 More from Biotivia
View Biotivia Safety Scorecard → 10 products
Acai Bio EdgeBio ForgeBio Forge Pro MaxBio Forge Pro Max Phase IIBio ShapeBio Span
7 Cite this page
Vancouver
Pkhakadze G. Transmax Tr — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 17]. Available from: https://supplement.ge/products/transmax-tr-33100/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG